Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 164

The DOI matches its Crossref record.

Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.

Open access
Dahlbäck, B · 1994 · Journal of Clinical Investigation

Abstract

Venous thromboembolism is a serious, potentially lethal health problem affecting 1 per 1,000 people annually (1-3).Major surgery, fractures, complicated pregnancy, the use of oral con- traceptives, and immobilization increase the risk of thrombosis.In addition, thrombosis is often familial, suggesting that genetic risk factors are involved (3-6).Until recently, the major genetic defects known to predispose for thrombosis were deficiencies of antithrombin III, protein C, and protein S. Together these did not account for more than 5-10% of the cases (3-5, 7).In the last year, hereditary activated protein C (APC)' resistance, has been identified as a basis for a majority of cases of familial thrombosis (8-13).In contrast to other genetic de- fects associated with thrombosis, APC resistance is highly prev- alent in the general population (8, 10).It afflicts affected individuals with a life-long increased risk of thrombosis.APC resistance, its molecular basis, and a short description of the protein C anticoagulant system will be presented.Balance between pro-and anticoagulant forces A number of plasma proteins function in harmony with cellular components to provide efficient and localized hemostasis (14, 15).Proteolytic events arranged in a cascade fashion lead to the explosive, but yet controlled formation of thrombin.Thrombin generated at sites of vascular injury activates factors V and VII (to Va and Villa) in a positive feedback reaction, activates and aggregates platelets and converts fibrinogen into insoluble fibrin (Fig. 1).Factors Va and Villa bind to negatively charged phos- pholipids exposed on activated platelets and serve as receptor sites for the proteolytic enzymes, factors IXa and Xa, respec- tively ( 15, 16).In contrast, at sites of intact vasculature, binding of thrombin to the endothelial membrane protein thrombo- modulin converts thrombin from a procoagulant into an antico- agulant protease, which activates protein C ( 17-19).APC inactivates the membrane bound factors Va and VIIIa by limited proteolysis in a reaction which is potentiated by a cofactor protein designated protein S. APC is highly specific in its action.It cleaves and inactivates cell surface bound factors Va and VIlla, but has no effect on circulating factors V and VI.Pro- and anticoagulant mechanisms are under physiological condi-

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci117458

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 164

Metadata

Authors
Dahlbäck, B.
Venue
Journal of Clinical Investigation
Published
1994-09-01
Volume
94
Issue
3
Pages
923-927
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2036117417
Cited by
164
References
0
FWCI
14.27
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. https://app.cochat.ai/papers/10.1172/jci117458
The paper
Dahlbäck, B. (1994). Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. Journal of Clinical Investigation. https://doi.org/10.1172/jci117458

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.